| 注册
首页|期刊导航|肿瘤预防与治疗|立体定向放射治疗联合免疫治疗非小细胞肺癌新进展

立体定向放射治疗联合免疫治疗非小细胞肺癌新进展

魏凌飞 林宇

肿瘤预防与治疗2024,Vol.37Issue(10):912-917,6.
肿瘤预防与治疗2024,Vol.37Issue(10):912-917,6.DOI:10.3969/j.issn.1674-0904.2024.10.011

立体定向放射治疗联合免疫治疗非小细胞肺癌新进展

New Advances in Stereotactic Radiotherapy Combined with Immunothera-py for Non-Small Cell Lung Cancer

魏凌飞 1林宇2

作者信息

  • 1. 010059 呼和浩特,内蒙古医科大学第一临床医学院
  • 2. 010010 呼和浩特,内蒙古医科大学附属医院放疗科
  • 折叠

摘要

Abstract

Lung cancer are the tumors with the highest incidence and mortality worldwide.Among them,non-small cell lung cancer is the most common pathological type of lung cancer,accounting for approximately 85%of all lung cancer cases.Stereotactic radiotherapy is one of the important treatment methods of non-small cell lung cancer.Among the treatments of tumor patients,immunotherapy has fewer toxic side effects and leads to good survival.The purpose of this review is to assess the therapeutic efficacy and research progress in non-small cell lung cancer by exploring the synergistic effects of stereotactic radiation therapy combined with immunotherapy and immune checkpoint inhibitors,as well as to delve into the basic princi-ples of combing stereotactic radiation therapy and immunotherapy and the potential value of such an approach in the treatment of non-small cell lung cancer,laying a solid theoretical foundation for the optimal application of stereotactic radiation therapy in combination with immunotherapy in order to improve its efficacy in non-small cell lung cancer patients.

关键词

非小细胞肺癌/立体定向放射治疗/免疫治疗/免疫检查点抑制剂/远隔效应

Key words

Non-small cell lung cancer/Stereotactic body radiation therapy/Immunotherapy/Immune checkpoint inhibi-tors/Abscopal effect

分类

医药卫生

引用本文复制引用

魏凌飞,林宇..立体定向放射治疗联合免疫治疗非小细胞肺癌新进展[J].肿瘤预防与治疗,2024,37(10):912-917,6.

基金项目

内蒙古自治区科技计划项目(编号:2021GG0204) (编号:2021GG0204)

内蒙古医科大学附属医院博士科研项目(编号:2022NYFYBS006) This study was supported by grants from Science and Technology Department of Inner Mongolia Autono-mous Region(No.2021GG0204)and Affiliated Hospital of Inner Mongolia Medical University(No.2022NYFYBS006). (编号:2022NYFYBS006)

肿瘤预防与治疗

OACSTPCD

1674-0904

访问量7
|
下载量0
段落导航相关论文